Walder Wyss AG acted as Swiss counsel to Nordic Infrastructure AG in this project. Solör Bioenergy Group’s main shareholder Nordic Infrastructure AG (NIAG) successfully completed the...
Nordic Infrastructure AG’s €215 Million Green Financing
Reata’s $275 Million Secured Term Loan Financing
Walder Wyss team advised the funds managed by Pharmakon Advisors, LP. Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a global pharmaceutical company primarily focused on investigating experimental oral...
UBS Switzerland AG’s €1.4 Billion Mutlicurrency Syndacated Revolving Credit Facility
Walder Wyss advised UBS Switzerland AG in the operation. UBS Switzerland AG operate as sole mandated lead arranger, sole bookrunner, agent and lender, with a syndicate of...
ImmunoGen’s $175 Million Term Loan Financing
Ropes & Gray advised ImmunoGen, while Walder Wyss advised the funds managed by Pharmakon Advisors. ImmunoGen, Inc. (Nasdaq: IMGN) announced it has entered into a term loan...
Insmed Incorporated’s $775 Million Financing
Covington advised Insmed Incorporated on the deal while Fenwick represented Pharmakon. Walder Wyss advised the funds managed by Pharmakon Advisors, LP, BioPharma Credit and OrbiMed. Akin...
Nordic Infrastructure AG’s €200 Million Green Financing
Walder Wyss AG acted as Swiss counsel to Nordic Infrastructure AG. Solör Bioenergy Group´s main shareholder Nordic Infrastructure AG (NIAG) successfully completed a EUR 200m Green...
PureFacts Financial Solutions’ Acquisition Of Quartal Financial Solutions
CMS advised the shareholders of Quartal on all legal matters of the transaction. Walder Wyss Ltd. advised PureFacts Financial Solutions. McCarthy Tétrault LLP advised The Bank...